Ergosterol biosynthesis and drug development for Chagas disease
This article presents an overview of the currently available drugs nifurtimox (NFX) and benznidazole (BZN) used against Trypanosoma cruzi, the aetiological agent of Chagas disease; herein we discuss their limitations along with potential alternatives with a focus on ergosterol biosynthesis inhibitor...
Main Author: | Julio A Urbina |
---|---|
Format: | Article |
Language: | English |
Published: |
Fundação Oswaldo Cruz (FIOCRUZ)
2009-07-01
|
Series: | Memorias do Instituto Oswaldo Cruz |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000900041 |
Similar Items
-
Glutamine metabolism modulates azole susceptibility in Trypanosoma cruzi amastigotes
by: Peter C Dumoulin, et al.
Published: (2020-12-01) -
Regulation of Ergosterol Biosynthesis in <i>Saccharomyces cerevisiae</i>
by: Tania Jordá, et al.
Published: (2020-07-01) -
Evolutionarily conserved Δ25(27)-olefin ergosterol biosynthesis pathway in the alga Chlamydomonas reinhardtii
by: Matthew B. Miller, et al.
Published: (2012-08-01) -
The Identification of <i>SQS</i>/<i>SQE</i>/<i>OSC</i> Gene Families in Regulating the Biosynthesis of Triterpenes in <i>Potentilla anserina</i>
by: Yangmiao Jiao, et al.
Published: (2023-03-01) -
Integration of (S)-2,3-oxidosqualene enables E. coli to become Iron Man E. coli with improved overall tolerance
by: Wenjie Sun, et al.
Published: (2023-12-01)